Inci Burcin Yildirim, MD, MSc

Assistant Professor, Pediatrics

Inci Yildirim
617.414.6395

Biography

Dr. Inci Yildirim is an Assistant Professor of Pediatrics and Attending Physician in Pediatric Infectious Diseases at Emory University School of Medicine. She trained at the Pediatrics residency at Yale University and completed infectious diseases fellowship at Boston Children’s Hospital/Boston Medical Center in Boston. She completed her Masters in Epidemiology and is currently a doctoral student at Boston University School of Public Health.

She was a recipient of the Massachusetts Infectious Disease Society’s Maxwell Finland Award for Excellence in Research, and Edward H. Kass Award for Clinical Excellence During Fellowship in 2015. Dr Yildirim’s research focuses on epidemiology of vaccine-preventable diseases particularly pneumococcal infections and cost-effectiveness of screening strategies for tuberculosis.

Other Positions

  • Doctoral Candidate, Epidemiology, Boston University School of Public Health
  • Boston Medical Center

Education

  • Hacettepe University, MD
  • Hacettepe University, MSc

Publications

  • Published on 8/23/2017

    Ceyhan M, Yildirim I, Tezer H, Devrim I, Feroldi E. A fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Turkish infants and toddlers Turk J Med Sci. 2017 08 23; 47(4):1247-1256. PMID: 29156870.

    Read at: PubMed
  • Published on 1/1/2017

    Clarke DF, Yildirim I, Cooper ER. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants. Pediatr Infect Dis J. 2017 Jan; 36(1):61-62. PMID: 27749654.

    Read at: PubMed
  • Published on 12/1/2015

    Yildirim I, Shea KM, Pelton SI. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine. Infect Dis Clin North Am. 2015 Dec; 29(4):679-97. PMID: 26610421.

    Read at: PubMed
  • Published on 2/2/2015

    Yildirim I, Shea KM, Little BA, Silverio AL, Pelton SI. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease. Pediatrics. 2015 Mar; 135(3):495-503. PMID: 25647674.

    Read at: PubMed
  • Published on 12/4/2014

    Yildirim, Inci; Shea, Kim; Silverio, Amy; Little, Brent; Pelton, Stephen. Vaccination, Underlying Comorbidities, and Risk of Invasive Pneumococcal Disease. Pediatrics (Accepted). 2014.

  • Published on 10/1/2012

    Yildirim I, Stevenson A, Hsu KK, Pelton SI. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods. Pediatr Infect Dis J. 2012 Oct; 31(10):1016-21. PMID: 22673142.

    Read at: PubMed
  • Published on 10/26/2010

    Yildirim I, Hanage WP, Lipsitch M, Shea KM, Stevenson A, Finkelstein J, Huang SS, Lee GM, Kleinman K, Pelton SI. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine. 2010 Dec 16; 29(2):283-8. PMID: 21029807.

    Read at: PubMed
  • Published on 4/1/2010

    Yildirim I, Ceyhan M, Bayrakci B, Uysal M, Kuskonmaz B, Ozaltin F. A case report of thrombocytopenia-associated multiple organ failure secondary to Salmonella enterica serotype Typhi infection in a pediatric patient: successful treatment with plasma exchange. Ther Apher Dial. 2010 Apr; 14(2):226-9. PMID: 20438547.

    Read at: PubMed
  • Published on 3/1/2010

    Aytaç S, Yildirim I, Ceyhan M, Cetin M, Tuncer M, Kara A, Cengiz AB, Seçmeer G, Yetgin S. Risks and outcome of fungal infection in neutropenic children with hematologic diseases. Turk J Pediatr. 2010 Mar-Apr; 52(2):121-5. PMID: 20560245.

    Read at: PubMed
  • Published on 1/20/2010

    Ceyhan M, Yildirim I, Sheppard CL, George RC. Pneumococcal serotypes causing pediatric meningitis in Turkey: application of a new technology in the investigation of cases negative by conventional culture. Eur J Clin Microbiol Infect Dis. 2010 Mar; 29(3):289-93. PMID: 20087750.

    Read at: PubMed

View 24 more publications: View full profile at BUMC

View all profiles